These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37771376)

  • 1. Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes
    Olsson M; Larsson P; Johansson J; Sah VR; Parris TZ
    Front Cell Dev Biol; 2023; 11():1237673. PubMed ID: 37771376
    [No Abstract]   [Full Text] [Related]  

  • 2. Transcriptional profiles of different states of cancer stem cells in triple-negative breast cancer.
    Liu M; Liu Y; Deng L; Wang D; He X; Zhou L; Wicha MS; Bai F; Liu S
    Mol Cancer; 2018 Feb; 17(1):65. PubMed ID: 29471829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard chemotherapy impacts on in vitro cellular heterogeneity in spheroids enriched with cancer stem cells (CSCs) derived from triple-negative breast cancer cell line.
    Moreira MP; Franco EP; Barros BAF; Anjos BRD; Almada DG; Barbosa INT; Braga LDC; Cassali GD; Silva LM
    Biochem Biophys Res Commun; 2024 Nov; 734():150765. PubMed ID: 39357337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44
    Chen J; Liu S; Su Y; Zhang X
    Transl Cancer Res; 2020 Mar; 9(3):1652-1659. PubMed ID: 35117513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic, structural, and ultrastructural analysis of triple-negative breast cancer cell lines and breast cancer stem cell subpopulation.
    Moreira MP; Brayner FA; Alves LC; Cassali GD; Silva LM
    Eur Biophys J; 2019 Oct; 48(7):673-684. PubMed ID: 31485678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.
    Tian J; Hachim MY; Hachim IY; Dai M; Lo C; Raffa FA; Ali S; Lebrun JJ
    Sci Rep; 2017 Jan; 7():40258. PubMed ID: 28054666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
    Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
    Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance.
    Hill DP; Harper A; Malcolm J; McAndrews MS; Mockus SM; Patterson SE; Reynolds T; Baker EJ; Bult CJ; Chesler EJ; Blake JA
    BMC Cancer; 2019 Nov; 19(1):1039. PubMed ID: 31684899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts.
    Liu S; Cong Y; Wang D; Sun Y; Deng L; Liu Y; Martin-Trevino R; Shang L; McDermott SP; Landis MD; Hong S; Adams A; D'Angelo R; Ginestier C; Charafe-Jauffret E; Clouthier SG; Birnbaum D; Wong ST; Zhan M; Chang JC; Wicha MS
    Stem Cell Reports; 2014 Jan; 2(1):78-91. PubMed ID: 24511467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells.
    Shiraishi A; Tachi K; Essid N; Tsuboi I; Nagano M; Kato T; Yamashita T; Bando H; Hara H; Ohneda O
    Cancer Sci; 2017 Mar; 108(3):362-372. PubMed ID: 28012234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer.
    Zhou L; Wang D; Sheng D; Xu J; Chen W; Qin Y; Du R; Yang X; He X; Xie N; Liu S; Zhang L
    Theranostics; 2020; 10(5):2405-2421. PubMed ID: 32104513
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
    Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
    Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
    Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
    Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell-derived CHI3L1 activates the MAF/CTLA4 signaling pathway to promote immune escape in triple-negative breast cancer.
    Ji S; Yu H; Zhou D; Fan X; Duan Y; Tan Y; Lang M; Shao G
    J Transl Med; 2023 Oct; 21(1):721. PubMed ID: 37838657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.
    Martin-Castillo B; Lopez-Bonet E; Cuyàs E; Viñas G; Pernas S; Dorca J; Menendez JA
    Oncotarget; 2015 Oct; 6(32):32317-38. PubMed ID: 26474458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers.
    Limsakul P; Choochuen P; Charupanit G; Charupanit K
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Cdk2 kinase activity selectively targets the CD44⁺/CD24⁻/Low stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
    Opyrchal M; Salisbury JL; Iankov I; Goetz MP; McCubrey J; Gambino MW; Malatino L; Puccia G; Ingle JN; Galanis E; D'Assoro AB
    Int J Oncol; 2014 Sep; 45(3):1193-9. PubMed ID: 24970653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer.
    Escudero Mendez L; Srinivasan M; Hamouda RK; Ambedkar B; Arzoun H; Sahib I; Fondeur J; Mohammed L
    Cureus; 2022 Aug; 14(8):e28056. PubMed ID: 36120232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dimensional Analysis of CD44
    Tan B; Kanoko M; Tan G; Bachtiar A; Munir D
    Open Access Maced J Med Sci; 2019 Feb; 7(4):526-528. PubMed ID: 30894906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.